Advanced Medical Solutions Ltd
2 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (2)
- Inspections (1)
Devices registered here (1)
- Dressing, Wound, DrugProduct code FRO (opens in a new tab) · Unclassified · Unknown
Recalls & enforcement
- Class IIOngoing2024-10-01Due to defects on primary packaging pouch that compromise the device's ability to maintain a sterile barrier.
- Class IITerminated2015-01-15On 08 January 2015 AMS Sole Customer for the products notified AMS of the issue after discovering the misplaced IFUs during its review of packaging in its warehouse
FDA inspections (1)
- VAI2016-06-23Voluntary Action Indicated · Compliance: Devices; Postmarket Assurance: Devices · citations posted
Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.
Related
- All facilities operated by ADVANCED MEDICAL SOLUTIONS GROUP PLC
- Resorba, s.r.o (CZ)
- RESORBA Medical GmbH (DE)
- Advanced Medical Solutions Limited (GB)
- BIOMATLANTE (FR)
- Medizin Produkte Neustadt GmbH (MPN) (DE)
- Advanced Medical Solutions Saal GmbH (DE)
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Advanced Medical Solutions Ltd (FEI 3003080333) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3003080333-advanced-medical-solutions-ltd/
Alerts for Advanced Medical Solutions Ltd
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.